Using Point of Care Testing to Transform Patient Care in General Practice and Primary Care Networks

Life Sciences, Healthcare, Laboratory Technology,
  • Friday, November 25, 2022

Over recent years, primary care has faced a growing number of challenges impacting both the public who use it, and the healthcare professionals working within these settings. Patients are experiencing difficulties accessing urgent care and general practice, affecting the ability to facilitate continuity of care to patients who need it. Primary care teams are finding themselves increasingly stretched beyond capacity1. Could point of care testing help transform patient care?

Featured speaker Dr. Mayur Lakhani is a practising GP Principal-Partner in Leicestershire and a Former President of the Royal College of Practitioners. Dr. Lakhani will discuss how implementing new models of care in general practice and PCNs (Primary Care Networks) using the LumiraDx Platform can assist in tackling the challenges faced within primary care. He will outline the benefits provided for patients and staff of earlier diagnosis and improved safety netting.

Read more...

Dr. Lakhani will also examine the implementation of point of care testing in PCNs in the context of the Fuller Stocktake report1, and how its adoption can assist in providing more integrated services in system, place and neighbourhood settings. With the introduction of PCNs, the Additional Roles Reimbursement Scheme (ARRS) includes funding for 26,000 essential roles to support PCNs in delivering more personalised and integrated health and social care2. The featured speakers will look at how introducing point of care testing could assist these roles in bringing change and improvements to patient care pathways.

With the National Health Service (NHS) committing to a target of becoming net zero by 20453, the speakers will explore how the implementation of point of care testing within primary care can assist in reaching this goal.

Dr. Lakhani will be joined by featured speaker Lucy Lehane, Global Medical Affairs Lead at LumiraDx, who will provide an overview of the LumiraDx point of care testing Platform.

Read Less...

Register for this webinar and learn about using point of care testing to transform patient care in general practice and primary care networks.

References:

  1. Fuller, C. (2022) Next Steps For Integrating Primary Care: Fuller Stocktake Report, NHS choices. NHS. Available at: https://www.england.nhs.uk/publication/next-steps-for-integrating-primary-care-fuller-stocktake-report/ (Accessed: October 24, 2022).
  2. Expanding our workforce (no date) NHS choices. NHS England. Available at: https://www.england.nhs.uk/gp/expanding-our-workforce/ (Accessed: October 24, 2022).
  3. Delivering a ‘Net Zero’ National Health Service (2020) NHS choices. NHS England and NHS Improvement. Available at: https://www.england.nhs.uk/greenernhs/ (Accessed: October 24, 2022).

Speakers

http://Dr.%20Mayur%20Lakhani%20CBE,%20GP%20Partner%20and%20ICB%20Board%20Member

Dr. Mayur Lakhani CBE, GP Partner and ICB Board Member

Dr. Mayur Lakhani is a practising GP Principal-Partner in Leicestershire where he has been in the same practice for 31 years. He is a Board Member and Chair of the Clinical Executive of the Leicester, Leicestershire and Rutland ICS. He was a senior Clinician on the national covid clinical assessment service (CCAS) and was instrumental in setting up the local Covid Medicines Delivery Unit and has recently completed training to be a Medical Examiner (RCPathME). He is a Fellow of three medical royal colleges. He is one of only 10 GPs to have been elected both Chair and President of the RCGP, the UK’s largest medical royal college. He is now the Chair of the Faculty of Medical Leadership and Management (FMLM), re-elected in 2022.  He was awarded the CBE in the Queen’s Birthday Honours list in 2007. He is the principal Author of the landmark document, “The Future Direction of General Practice: A Roadmap”, where he first advocated the idea of federations, the forerunners of primary care networks. He was Chair of the National Council for Palliative Care from 2008 to 2015, where he championed the cause of high-quality care at the end of life for all.

Message Presenter
http://Lucy%20Lehane,%20LumiraDx

Lucy Lehane, Associate Director Medical Affairs, LumiraDx

Lucy studied for her first degree in London at the University of Westminster, where her dissertation on POCT in cardiac markers was published in the Journal of Emergency Medicine. She went on to study for her master’s in medical diagnostics at Cranfield University, in the UK. Lucy began her career in the UK National Health Service as a Biomedical Scientist and then moved to the commercial world of diagnostic technology. For more than 20 years, Lucy has worked in global roles for diagnostic companies developing both consumer and POC devices — across the product development process and most recently, leading International Medical Affairs at LumiraDx.

Message Presenter

Who Should Attend?

  • Consultants
  • POCT Coordinators
  • GPs
  • Primary Care Consultants/Clinicians
  • Primary Care Managers
  • NHS/Procurement Managers
  • Nurses
  • Healthcare Professionals

What You Will Learn

Attendees will gain insights into:

  • The experience of using point of care testing in general practice
  • Benefits for patients, general practitioners (GPs) and the Integrated Care System (ICS)
  • Contribution to sustainability and the National Health Service (NHS) Net Zero Carbon Footprint model

Xtalks Partner

LumiraDx

LumiraDx develops, manufactures and commercializes an innovative point of care diagnostic Platform, a next generation point of care diagnostic system that combines a small portable Instrument; microfluidic Test Strip; simple, standardized workflow; and seamless, secure digital connectivity to the Cloud and hospital IT systems. The LumiraDx Platform leverages testing methodologies used in lab analyzer systems to deliver lab comparable performance at the point of care in minutes across a broad test menu, in a portable, easy-to-use point of care solution.

LumiraDx recently launched the SARS-CoV-2 Antigen Test for use on the LumiraDx Platform which delivers results in 12 minutes with 97.6% PPA to an EUA approved RT-PCR method within the first 12 days of symptom onset.

In addition to COVID-19 and other tests already available under CE mark, the Platform integrated several testing technologies and sample types into a single Instrument, allowing continued development across a broad test menu.

Media Partner

The original site for employees in the pharma, medical, diagnostic and related industries. Our hand-curated daily news feed and active message forums will keep you informed.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account